Even more than that when you consider that they will have to add back all the training expense and discount off the headline price of which may be offered on extended settlement terms. Really need to be very wary of headline numbers or simple multiplication by Recommended pricing as it will be heavily discounted IMO as they need turnover with such a short dated product . Yes they may play the game of show revenue this quarter and rebates show up next and try and disguise the actual sale price but the big players know and will be getting all the IMS data . Only retail stock holders will be sucked in and it will only work for a pump and then if not sustained by bigger and bigger sales numbers
Reality is that AVH have to fit in with the cycle of hospital board approval meetings ( many only quarterly or 6 monthly) and then into the cycle of introducing new product and new accounts etc. They say they have done some work and expect some early sales to existing users but not sure until we see the numbers just how much they can short circuit the usual process and what work they have done elsewhere in the market.
Those headline sales prices for initial sales will be are hard one considering they want to change the pricing to existing users , hospitals and surgeons and that won't happen or will be rebated as these are the very people who supported them in trials etc. They don't want to bite the hand that feeds them especially if they want surgeons to continue to participate in further trials etc.
- Forums
- ASX - By Stock
- AVH
- Ann: Randomized Controlled Clinical Study of RECELL System
Ann: Randomized Controlled Clinical Study of RECELL System, page-20
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.80 |
Change
-0.030(1.06%) |
Mkt cap ! $197.1M |
Open | High | Low | Value | Volume |
$2.83 | $2.89 | $2.80 | $299.8K | 105.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3700 | $2.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.83 | 10724 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 700 | 2.790 |
1 | 2400 | 2.780 |
1 | 500 | 2.770 |
1 | 2000 | 2.760 |
1 | 4000 | 2.750 |
Price($) | Vol. | No. |
---|---|---|
2.830 | 10724 | 2 |
2.870 | 14722 | 3 |
2.880 | 14249 | 3 |
2.890 | 9500 | 1 |
2.900 | 5050 | 4 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online